A Clinical Study to Evaluate the Safety of Ospemifene
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and long-term safety of 60mg
ospemifene in the treatment of VVA in postmenopausal women with intact uterus.